Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
KZR-261 inhibits Sec61, potentially leading to inhibition of tumor growth (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 2515-2515).
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|KZR-261||KZR 261|KZR261||KZR-261 inhibits Sec61, potentially leading to inhibition of tumor growth (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 2515-2515).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT05047536||Phase I||KZR-261||KZR-261 in Subjects With Advanced Solid Malignancies||Recruiting||USA||0|